IPP Bureau
PAGE, 8chili Inc. collaborate to scale AI-powered pharma training ecosystem
By IPP Bureau - April 23, 2026
Platform integrates VR simulations and AI-driven coaching to build job-ready skills in pharma manufacturing
Cipla’s generic Ventolin HFA secures USFDA approval
By IPP Bureau - April 23, 2026
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
Experts convene in India to push for urgent action on dengue treatment gaps
By IPP Bureau - April 23, 2026
Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
Japanese pharma firms turn to CDMOs early as peptide complexity rises
By IPP Bureau - April 23, 2026
Neuland Laboratories reported an uptick in peptide-related engagements from Japanese companies, particularly at the preclinical and early clinical stages
Lupin launches Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets in USA
By IPP Bureau - April 23, 2026
The product is approved as bioequivalent to Xigduo XR for the indications outlined in the reference drug’s labelling
Medtronic launches adaptive deep brain stimulation system for Parkinson’s in India
By IPP Bureau - April 23, 2026
The system is powered by BrainSense technology, which has received approval from USFDA
Vice-President calls for integrity in medical practice at AIIMS Rishikesh convocation
By IPP Bureau - April 23, 2026
C. P. Radhakrishnan urged graduates to uphold ethical standards and maintain a commitment to patient care
Crown Bioscience partners with Turbine to accelerate translational oncology research
By IPP Bureau - April 22, 2026
The collaboration underscores a broader industry shift toward hybrid research models that integrate computational biology with advanced experimental systems
ProBioGen appoints Dr Simon Johannes Bulling as its new Chief Operating Officer
By IPP Bureau - April 22, 2026
Bulling brings extensive experience across the biopharma and CDMO landscape, with leadership roles spanning both drug substance and drug product operations
New brain study reveals why alcohol relapse remains a persistent challenge
By IPP Bureau - April 22, 2026
These findings help explain how relapse-triggering memories can persist alongside those that support recovery
HCL Healthcare opens Bengaluru office to deepen enterprise client engagement
By IPP Bureau - April 22, 2026
New regional hub strengthens presence in a key market and enhances service delivery for corporate healthcare clients
New guardian protein mechanism identified in aggressive skin cancer progression
By IPP Bureau - April 22, 2026
While many cases are treatable, a subset can become highly aggressive, spreading to distant organs and resisting conventional therapies
ECI taps industry veteran Khalid Raja to drive strategic growth
By IPP Bureau - April 22, 2026
Move comes amid rising regulatory pressures
US FDA okays Merck's new once-daily HIV pill
By IPP Bureau - April 22, 2026
The newly approved pill combines 100 mg of doravirine with 0.25 mg of islatravir
Pfizer unleashes wave of breakthrough cancer data at ASCO 2026
By IPP Bureau - April 22, 2026
Pharma giant targets new standards of care
